Next Article in Journal
Impact of BNT162b2 Booster Dose on SARS-CoV-2 Anti-Trimeric Spike Antibody Dynamics in a Large Cohort of Italian Health Care Workers
Next Article in Special Issue
A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge
Previous Article in Journal
Immunological Findings in a Group of Individuals Who Were Poor or Non-Responders to Standard Two-Dose SARS-CoV-2 Vaccines
Previous Article in Special Issue
A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines
 
 
Article

Article Versions Notes

Vaccines 2023, 11(2), 462; https://doi.org/10.3390/vaccines11020462
Action Date Notes Link
article xml file uploaded 17 February 2023 04:33 CET Original file -
article xml uploaded. 17 February 2023 04:33 CET Update https://www.mdpi.com/2076-393X/11/2/462/xml
article pdf uploaded. 17 February 2023 04:33 CET Version of Record https://www.mdpi.com/2076-393X/11/2/462/pdf
article supplementary file uploaded. 17 February 2023 04:33 CET - https://www.mdpi.com/2076-393X/11/2/462#supplementary
article html file updated 17 February 2023 04:34 CET Original file -
article html file updated 9 March 2023 20:33 CET Update https://www.mdpi.com/2076-393X/11/2/462/html
Back to TopTop